scholarly article | Q13442814 |
P50 | author | Shidong Xu | Q89848881 |
Kaibin Zhu | Q89848875 | ||
Lantao Chen | Q89848876 | ||
Changjun He | Q89848877 | ||
Yaoguo Lang | Q89848878 | ||
Xianglong Kong | Q89848879 | ||
Changfa Qu | Q89848880 | ||
P2860 | cites work | Visceral pleural invasion by pulmonary adenocarcinoma ≤3 cm: the pathological correlation with pleural signs on computed tomography | Q91266682 |
High-Risk Factors for Recurrence of Stage I Lung Adenocarcinoma: Follow-up Data From JCOG0201 | Q92123037 | ||
CT-defined Visceral Pleural Invasion in T1 Lung Adenocarcinoma: Lack of Relationship to Disease-Free Survival | Q92283723 | ||
Progression and metastasis of lung cancer | Q28066865 | ||
Visceral pleural invasion remains a size-independent prognostic factor in stage I non-small cell lung cancer | Q35565408 | ||
Pleural involvement in lung cancer. | Q35739559 | ||
Unexpected extensions of non-small-cell lung cancer diagnosed during surgery: revisiting exploratory thoracotomies and incomplete resections | Q36778573 | ||
Surgery for metastatic pleural extension of non-small-cell lung cancer. | Q37868282 | ||
Predicting pleural invasion using HRCT and 18F-FDG PET/CT in lung adenocarcinoma with pleural contact. | Q38542766 | ||
Lung Cancer Biomarkers | Q38608167 | ||
The Eighth Edition Lung Cancer Stage Classification | Q38990745 | ||
Diagnosis and management of malignant pleural effusions | Q40551721 | ||
Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis. | Q42318305 | ||
Preoperative staging of lung cancer with combined PET-CT. | Q43608939 | ||
Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer | Q47708974 | ||
A quantitative evaluation of pleural effusion on computed tomography scans using B-spline and local clustering level set. | Q47827895 | ||
Evaluation of chest wall invasion by lung cancer using respiratory dynamic MRI. | Q53426314 | ||
Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. | Q53667726 | ||
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer | Q57272532 | ||
Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible? | Q58591218 | ||
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† | Q59587188 | ||
Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer | Q60959695 | ||
Prediction of pleural invasion using different imaging tools in non-small cell lung cancer | Q64258748 | ||
A Prediction Rule for Overall Survival in Non-Small-Cell Lung Cancer Patients with a Pathological Tumor Size Less Than 30 mm. | Q64944417 | ||
Evaluation of parietal pleural invasion of lung cancers with breathhold inspiration and expiration MRI | Q73346546 | ||
Normal volume and cellular contents of pleural fluid | Q76379857 | ||
Cine MRI enables better therapeutic planning than CT in cases of possible lung cancer chest wall invasion | Q84961132 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | 6430459 | |
P577 | publication date | 2020-02-07 | |
P1433 | published in | Disease Markers | Q15756044 |
P1476 | title | Prediction of Pleural Invasion in Challenging Non-Small-Cell Lung Cancer Patients Using Serum and Imaging Markers | |
P478 | volume | 2020 |